Literature DB >> 22033037

Roles of ubiquitin signaling in transcription regulation.

Ian Hammond-Martel1, Helen Yu1, El Bachir Affar2.   

Abstract

Rivaling or cooperating with other post-translational modifications, ubiquitination plays central roles in regulating numerous cellular processes. Not surprisingly, gain- or loss-of-function mutations in several components of the ubiquitin system are causally linked to human pathologies including cancer. The covalent attachment of ubiquitin to target proteins occurs in sequential steps and involves ubiquitin ligases (E3s) which are the most abundant enzymes of the ubiquitin system. Although often associated with proteasomal degradation, ubiquitination is also involved in regulatory events in a proteasome-independent manner. Moreover, ubiquitination is reversible and specific proteases, termed deubiquitinases (DUBs), remove ubiquitin from protein substrates. While we now appreciate the importance of ubiquitin signaling in coordinating a plethora of physio-pathological processes, the molecular mechanisms are not fully understood. This review summarizes current findings on the critical functions exerted by E3s and DUBs in transcriptional control, particularly chromatin remodeling and transcription initiation/elongation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033037     DOI: 10.1016/j.cellsig.2011.10.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  54 in total

1.  Histone H2B monoubiquitination is involved in regulating the dynamics of microtubules during the defense response to Verticillium dahliae toxins in Arabidopsis.

Authors:  Min Hu; Bao-Lei Pei; Li-Fan Zhang; Ying-Zhang Li
Journal:  Plant Physiol       Date:  2014-02-24       Impact factor: 8.340

Review 2.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

3.  Deltex2 represses MyoD expression and inhibits myogenic differentiation by acting as a negative regulator of Jmjd1c.

Authors:  Dan Luo; Antoine de Morree; Stephane Boutet; Navaline Quach; Vanita Natu; Arjun Rustagi; Thomas A Rando
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-28       Impact factor: 11.205

4.  The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

Authors:  Tyler B Faust; Yang Li; Curtis W Bacon; Gwendolyn M Jang; Amit Weiss; Bhargavi Jayaraman; Billy W Newton; Nevan J Krogan; Iván D'Orso; Alan D Frankel
Journal:  Elife       Date:  2018-05-30       Impact factor: 8.140

Review 5.  Roles of proteolysis in regulation of GPCR function.

Authors:  G S Cottrell
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Inhibition of the ubiquitin ligase activity improves the production of biologically active fusion protein HSA-HGF in Chinese hamster ovary cells.

Authors:  Dongsheng Xu; Aini Wan; Jingjing Zhang; Lin Peng; Yun Chen; Yang He; Jianfeng Yang; Jian Jin
Journal:  Bioengineered       Date:  2016-10-18       Impact factor: 3.269

Review 7.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

8.  ASH2L regulates ubiquitylation signaling to MLL: trans-regulation of H3 K4 methylation in higher eukaryotes.

Authors:  Lipeng Wu; Shirley Y Lee; Bo Zhou; Uyen T T Nguyen; Tom W Muir; Song Tan; Yali Dou
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

Review 9.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

Review 10.  When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

Authors:  Zhao-Hui Wu; Yuling Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.